Beam Therapeutics Inc. (BEAM) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Beam Therapeutics Inc BEAM
$28.64
▲ +3.51%
(+$0.97)
Open
$27.70
Prev Close
$27.67
Day Range
$27.63 – $29.14
52W Range
$15.35 – $36.44
Market Cap
$2.95B
Beta
2.19
EPS (TTM)
$-0.64
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-02-06 |
| Shares Out. | 102,880,000 |
| Website | beamtx.com/ ↗ |
| Phone | 13026587581 |
Beam Therapeutics Inc is a publicly traded company under the ticker symbol BEAM on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
25 analysts (2026-05-01)
📰 Latest News for BEAM
These Are The Upcoming Catalysts For Crispr Therapeutics Stock
Beam Therapeutics Inc. (BEAM) Presents at ATS 2026 International Conference - Slideshow
Beam Therapeutics Presented Clinical Data From Phase 1/2 Trial For BEAM-302 Treatment For Alpha-1 Antitrypsin Deficiency At American Thoracic Society International Conference In Orlando, FL
Bernstein Maintains Outperform on Beam Therapeutics, Lowers Price Target to $39
Beam Therapeutics: Base Editing Is Moving From Platform Story To Regulatory Asset Story
Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare Conference
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2026 Update